Type I interferons in tuberculosis: Foe and occasionally friend

L Moreira-Teixeira, K Mayer-Barber, A Sher… - Journal of Experimental …, 2018 - rupress.org
Tuberculosis remains one of the leading causes of mortality worldwide, and, despite its
clinical significance, there are still significant gaps in our understanding of pathogenic and …

[PDF][PDF] Type I interferons in tuberculosis: Foe and occasionally friend

L Moreira‑Teixeira, K Mayer‑Barber, A Sher… - J. Exp …, 2018 - scholar.archive.org
The host beneficial protective effects of type I IFN have been most thoroughly studied in viral
infections where these cytokines stimulate the production of innate antiviral proteins and …

Type I interferons in tuberculosis: Foe and occasionally friend

L Moreira-Teixeira, K Mayer-Barber… - The Journal of …, 2018 - pubmed.ncbi.nlm.nih.gov
Tuberculosis remains one of the leading causes of mortality worldwide, and, despite its
clinical significance, there are still significant gaps in our understanding of pathogenic and …

Type I interferons in tuberculosis: Foe and occasionally friend.

L Moreira-Teixeira, K Mayer-Barber, A Sher… - The Journal of …, 2018 - europepmc.org
Tuberculosis remains one of the leading causes of mortality worldwide, and, despite its
clinical significance, there are still significant gaps in our understanding of pathogenic and …

[PDF][PDF] Type I interferons in tuberculosis: Foe and occasionally friend

L Moreira‑Teixeira, K Mayer‑Barber, A Sher, A O'Garra - 2018 - pdfs.semanticscholar.org
The host beneficial protective effects of type I IFN have been most thoroughly studied in viral
infections where these cytokines stimulate the production of innate antiviral proteins and …

[引用][C] Type I interferons in tuberculosis: Foe and occasionally friend

L Moreira-Teixeira, K Mayer-Barber, A Sher… - Journal of …, 2018 - jglobal.jst.go.jp
Type I interferons in tuberculosis: Foe and occasionally friend | Article Information | J-GLOBAL
Art J-GLOBAL ID:202102267643560377 Reference number:21A0282267 Type I interferons …

Type I interferons in tuberculosis: Foe and occasionally friend

L Moreira-Teixeira, K Mayer-Barber, A Sher, A O'Garra - 2018 - crick.figshare.com
Tuberculosis remains one of the leading causes of mortality worldwide, and, despite its
clinical significance, there are still significant gaps in our understanding of pathogenic and …

[HTML][HTML] Type I interferons in tuberculosis: Foe and occasionally friend

L Moreira-Teixeira, K Mayer-Barber… - The Journal of …, 2018 - ncbi.nlm.nih.gov
Tuberculosis remains one of the leading causes of mortality worldwide, and, despite its
clinical significance, there are still significant gaps in our understanding of pathogenic and …

Type I interferons in tuberculosis: Foe and occasionally friend

L Moreira-Teixeira, K Mayer-Barber, A Sher… - Journal of Experimental …, 2018 - cir.nii.ac.jp
抄録< jats: p> Tuberculosis remains one of the leading causes of mortality worldwide, and,
despite its clinical significance, there are still significant gaps in our understanding of …

[PDF][PDF] Type I interferons in tuberculosis: Foe and occasionally friend

L Moreira‑Teixeira, K Mayer‑Barber, A Sher, A O'Garra - 2018 - core.ac.uk
The host beneficial protective effects of type I IFN have been most thoroughly studied in viral
infections where these cytokines stimulate the production of innate antiviral proteins and …